Concepedia

ChiehYing Y. Chang

CY

Statistics

Publications

21

Citations

1.2K

H-Index

17

Active since

1994

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Protein Express (United States)

Bristol-Myers Squibb (Sweden)

Dana-Farber Cancer Institute

ChiehYing Y. Chang is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, drug discovery, and medicinal chemistry.

Publications per year

1994–2020

21

Publications

21

Human mannose-binding protein carbohydrate recognition domain trimerizes through a triple α-helical coiled-coil

S. Sheriff, ChiehYing Y. Chang, R. Alan B. Ezekowitz · Nature Structural Biology · 1994 · 249 citations

, , +12

Discovery of a 1<i>H</i>-Benzoimidazol-2-yl)-1<i>H</i>-pyridin-2-one (BMS-536924) Inhibitor of Insulin-like Growth Factor I Receptor Kinase with in Vivo Antitumor Activity

Mark D. Wittman, Joan M. Carboni, Ricardo M. Attar et al. · Journal of Medicinal Chemistry · 2005 · 135 citations · Full text

, , +11

Tyrosine Kinase 2-mediated Signal Transduction in T Lymphocytes Is Blocked by Pharmacological Stabilization of Its Pseudokinase Domain

John S. Tokarski, Adriana Zupa-Fernandez, Jeffrey Tredup et al. · Journal of Biological Chemistry · 2015 · 116 citations · Full text

, , +17

The X-ray structure of an anti-tumour antibody in complex with antigen

Philip D. Jeffrey, Jürgen Bajorath, ChiehYing Y. Chang et al. · Nature Structural & Molecular Biology · 1995 · 92 citations

, , +14

Identification of <i>N</i>-Methyl Nicotinamide and <i>N</i>-Methyl Pyridazine-3-Carboxamide Pseudokinase Domain Ligands as Highly Selective Allosteric Inhibitors of Tyrosine Kinase 2 (TYK2)

Ryan Moslin, Yanlei Zhang, Stephen T. Wrobleski et al. · Journal of Medicinal Chemistry · 2019 · 92 citations · Full text

, , +17

1–5 of 21